Your Best Stock

Johnson & Johnson JNJ

$271.49
+$2.32 (+0.86%)
Market open · Sep 24, 2:00 pm ET
After hours $268.71 -0.17%
Open$269.50
Prev close$269.17
Day range$269.01 – $275.23
Volume2.78M
Market cap$654.25B
P/E (TTM)31.5
Dividend yield1.93%

Earnings

Average move on report day±2.1%last 15 reports
Closed higher5 of 1533% of the time
Best reaction+6.2%
Worst reaction-2.8%

Stock move on the day after each report

-0.9%2023/Q3-1.6%2023/Q4-2.1%2024/Q1+3.7%2024/Q2+1.5%2024/Q3-1.9%2024/Q4-0.5%2025/Q1+6.2%2025/Q20.0%2025/Q3-0.1%2025/Q4+0.9%2026/Q1-2.7%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q313 Oct 2026Pre Market–––
2026/Q215 Jul 2026Pre Market±7.5%-2.69%Within range
2026/Q114 Apr 2026Pre Market±7.2%+0.90%Within range
2025/Q421 Jan 2026Pre Market±6.1%-0.09%Within range
2025/Q314 Oct 2025Pre Market±5.2%-0.03%Within range
2025/Q216 Jul 2025Pre Market±4.4%+6.19%Bigger than priced
2025/Q115 Apr 2025Pre Market±4.5%-0.48%Within range
2024/Q422 Jan 2025Pre Market±3.7%-1.94%Within range
2024/Q315 Oct 2024Pre Market±4.5%+1.55%Within range
2024/Q217 Jul 2024Pre Market±4.2%+3.69%Within range
2024/Q116 Apr 2024Pre Market±4.1%-2.13%Within range
2023/Q423 Jan 2024Pre Market±4.3%-1.64%Within range
2023/Q317 Oct 2023Pre Market±4.3%-0.91%Within range
2023/Q220 Jul 2023Pre Market±4.4%+6.07%Bigger than priced
2023/Q118 Apr 2023Pre Market±4.3%-2.81%Within range
2022/Q424 Jan 2023Pre Market±4.8%+0.00%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Innovative Medicine$16.38B 64.7%
  • MedTech$8.93B 35.3%

Latest reported quarter: Q2, ended Jun 2026

Revenue$25.31B+6.6% YoY
Operating profit$7.17B+6.9% YoY
Net profit$5.53B-0.1% YoY
Diluted EPS$2.27-0.9% YoY
Free cash flow$7.30B+194.2% YoY
Operating cash flow$8.62B

Revenue, last 8 quarters

$22.5BSep '24$22.5BDec '24$21.9BMar '25$23.7BJun '25$24.0BSep '25$24.6BDec '25$24.1BMar '26$25.3BJun '26

Net profit, last 8 quarters

$2.7BSep '24$3.4BDec '24$11.0BMar '25$5.5BJun '25$5.2BSep '25$5.1BDec '25$5.2BMar '26$5.5BJun '26

Profitability & balance sheet

Gross margin67.9%
Operating margin26.8%
Net margin21.5%
Return on equity25.7%
Return on assets10.7%
Return on invested capital16.0%
Current ratio1.09
Liabilities / assets57.7%
Cash & investments$20.76B
Total debt$49.04B
Net cash (debt)-$28.28B
Free cash flow / sales22.7%
Scroll to Top